Who Is WHO - Role Of This Organization During And Postpandemic
Author: LawSphereX
Category: General Law
Published:
Updated:
WHO IS WHO: ROLE OF THIS ORGANIZATION DURING
AND POST PANDEMIC
Ms. Stuti Oswal, Shri. Navalmal Firodia Law College, Pune
ABSTRACT
In the complex arena of international law, the World Health Organization (WHO) emerges as a pivotal entity, its role accentuated amidst and beyond the COVID-19 pandemic. This research delves into the realm of international law, spotlighting the WHO's crucial role in navigating global health crises. The World Health Organisation (WHO) was established on 7th April, 1948, as a specialized agency of the United Nations. During the COVID-19 pandemic, the World Health Organization (WHO) played a central role in coordinating global responses, disseminating information, and advising member states on containment strategies. Post- pandemic, the WHO's role continues to evolve, emphasizing the importance of international collaboration, equitable vaccine distribution, and strengthening health systems to mitigate future crises.
Through a meticulous analysis of its functions, we uncover the WHO's pivotal role in shaping legal frameworks and guiding member states through turbulent times. The WHO remains at the forefront of efforts to address ongoing challenges such as vaccine distribution disparities, misinformation, and emerging variants, while also advocating for long-term investments in public health infrastructure and preparedness measures worldwide. However, as the pandemic unfolded, it unveiled challenges, prompting crucial questions about the WHO's efficacy and authority. This research poses central question as to what extent has the WHO fulfilled its legal obligations during the COVID-19 pandemic, and how can it fortify its role post-pandemic.
The hypothesis of this research is that by reinforcing accountability, fostering greater cooperation among member states, and reinforcing legal frameworks, the WHO can navigate future health crises while upholding international law. Through this research, we aim to deepen our understanding of the intricate relationship between international law and global health governance, offering insights transcending academic realms. Keywords: World Health Organization, COVID-19, pandemic, health crises, vaccine, international law.
1. Introduction
The COVID-19 pandemic underscored the critical role of international organizations in tackling global health threats. Central to this response is the World Health Organization (WHO), a specialized agency of the United Nations established in 1948. This paper delves into WHO's multifaceted role during and after pandemics, analyzing its functions within the framework of international law. Understanding "Who is WHO" necessitates an examination of its core mandate. The WHO Constitution, its foundational treaty, outlines its primary objective as achieving "the highest level of health for all peoples". This translates into a range of functions, including disease surveillance, issuing technical guidance, coordinating international responses, and promoting research and development. The paper will explore how these functions intersect with key international legal instruments.
The International Health Regulations (IHR) 2005, a binding treaty, outlines state obligations for reporting public health emergencies of international concern (PHEICs) and implementing core capacities for response. Analyzing WHO's actions within the IHR framework allows for a critical assessment of its effectiveness in fostering international cooperation during pandemics. Beyond immediate crisis response, WHO plays a crucial role in strengthening global health systems through promoting access to essential medicines and vaccines, fostering research, and addressing emerging challenges. By analyzing WHO's actions through this legal lens, the paper aims to provide a comprehensive understanding of its vital role in navigating global health challenges.
Exploring both its successes and limitations during and after the COVID-19 pandemic will offer valuable insights for strengthening international cooperation and building a more resilient global health architecture.
2. Historical Background
The International Sanitary Conferences (ISC), inaugurated on June 23, 1851, constituted a series of gatherings spanning 87 years until 1938. 1 The inaugural conference held in Paris primarily focused on addressing cholera, a prevailing concern throughout much of the 19th century. As the causes, origins, and modes of transmission of epidemic diseases remained uncertain, achieving international consensus on appropriate measures posed a formidable challenge. It took seven such conferences, spanning 41 years, before a multi-state international agreement was reached. The seventh conference, convened in Venice in 1892, marked a breakthrough as it culminated in the establishment of a convention. This convention specifically addressed the sanitary regulation of shipping traversing the Suez Canal, aimed at preventing the spread of cholera through importation.
In 1897, 16 out of the 19 states participating in the Venice conference signed a convention pertaining to the bubonic plague. Although Denmark, Sweden-Norway, and the United States abstained from signing this convention, unanimous consent was reached on the need to codify the outcomes of preceding conferences for implementation. Subsequent conferences, held from 1902 until the final assembly in 1938, expanded the scope of concerns addressed by the ISC. Discussions encompassed responses to a variety of diseases including yellow fever, brucellosis, leprosy, tuberculosis, and typhoid. 2 When the League of Nations was formed in 1920, it established the Health Organization of the League of Nations. After World War II, the United Nations absorbed all the other health organizations, to form the WHO.
3 During the United Nations formation conference in 1945, diplomats deliberated on the establishment of a global health organization. The fruition of this discussion materialized with the enactment of the World Health Organization's Constitution on April 7, 1948, a date commemorated annually as World Health Day. In April 1945, at the UN establishment conference in San Francisco, representatives from Brazil and China advocated for the creation of an international health organization, prompting the convocation of a conference to formulate its constitution. The Economic and Social Council of the UN, on February 15, 1946, instructed the Secretary-General to convene such a conference. Subsequently, a Technical Preparatory Committee met in Paris from March 18 to April 5, 1946, generating proposals for the Constitution.
These proposals were presented at the International Health Conference in New York City, held between June 19 and July 22, 1946. Based on these deliberations, representatives of 51 UN Member States and 10 other nations signed the Constitution of the World Health Organization on July 22, 1946. The Conference also established an Interim Commission tasked with executing certain functions of existing health institutions until the Constitution of the World Health Organization came into force. The preamble and Article 69 of WHO's Constitution stipulate its designation as a specialized agency of the UN. Article 80 outlines that the Constitution would become effective upon ratification by 26 members of the United Nations. However, it was not until April 7, 1948, that the Constitution officially came into force, following the ratification by the 26th government out of the 61 signatory nations.
The inaugural Health Assembly commenced in Geneva on June 24, 1948, with delegations from 53 out of the 55 Member States in attendance. The Assembly decreed the cessation of the Interim Commission's operations at midnight on August 31, 1948, to be immediately succeeded by the establishment of WHO. 4
4. Importance and Significance of Global Health Governance
Global health governance stands at the forefront of addressing the intricate challenges posed by pandemics and health crises, such as the one witnessed during the COVID-19 pandemic. The contemporary world is characterized by unparalleled interconnectivity, wherein diseases recognize no borders and can spread rapidly across continents. In this context, the significance of effective global health governance cannot be overstated. This essay explores the importance of global health governance, highlighting the role of organizations like the World Health Organization (WHO) during and post-pandemic scenarios, within the framework of international law. i.
Global Health Governance: A Crucial Framework Global health governance refers to the collective efforts of international organizations, governments, civil society, and other stakeholders to address health issues that transcend national boundaries. It encompasses the development and implementation of policies, regulations, and mechanisms aimed at promoting and safeguarding public health on a global scale. At its core, global health governance seeks to ensure equitable access to healthcare, disease prevention, and response to health emergencies. 5 ii. The Role of WHO: Leading Global Heath Efforts One of the WHO's primary objectives is to ensure everyone, everywhere has access to quality healthcare services. This concept, known as universal health coverage (UHC), is a cornerstone of achieving health equity.
The WHO promotes UHC by focusing on strengthening primary healthcare systems, which are the first point of contact for most people seeking healthcare. 6 This includes advocating for sustainable financing mechanisms, ensuring access to essential medicines and health products, and fostering a well-trained health workforce. The WHO's work on UHC extends beyond resource allocation. It also emphasizes policy development and data collection. The organization provides technical assistance to countries in formulating national health plans and strengthening health information systems. Robust data is essential for identifying gaps in healthcare access and monitoring progress towards UHC goals. 7 During pandemics, the WHO serves as a crucial coordinator, providing guidance to member states, facilitating information sharing, and mobilizing resources for response efforts. 8 iii.
The Significance of Global Health Regulations International law provides a crucial framework for global health governance, facilitating cooperation and coordination among states and international organizations. The International Health Regulations (IHR) serve as a cornerstone of global health governance, providing a legal framework for the prevention and response to infectious disease outbreaks. Enacted by the WHO in 2005, the IHR require countries to develop core capacities for disease surveillance, reporting, and response, thereby enhancing global health security. iv. Challenges and Opportunities in Global Health Governance Despite its importance, global health governance faces various challenges, including inadequate funding, geopolitical tensions, and weak health systems in many countries.
The COVID-19 pandemic has underscored the need for reforms and strengthened collaboration to address these challenges effectively. Additionally, the post-pandemic era presents an opportunity to enhance global health governance by investing in resilient health systems, promoting health equity, and strengthening international cooperation. In conclusion, global health governance, spearheaded by organizations like the WHO, plays a pivotal role in addressing health challenges at the global level. Through coordination, cooperation, and adherence to international law, global health governance can effectively mitigate the impact of pandemics and safeguard public health worldwide. As the world continues to grapple with the aftermath of the COVID-19 pandemic, strengthening global health governance remains imperative for building a healthier and more resilient future.
5. Structure and Governance
The World Health Organization (WHO) stands as a cornerstone of global health, and its structure and governance mechanisms are fundamental to understanding its effectiveness, particularly during the COVID-19 pandemic and beyond. This section delves into the WHO's organizational framework, decision-making processes, and funding sources, analyzing their impact on pandemic response and future preparedness. A. Organizational Framework- The WHO's structure comprises three main organs9: i. The World Health Assembly (WHA): The WHA serves as the WHO's highest decision-making body. Composed of delegates from all member states, it convenes annually to set overarching policies, approve budgets, and elect the Director-General.
During the pandemic, the WHA played a crucial role by issuing resolutions urging international cooperation on COVID-19 control measures and endorsing the COVAX Facility, which aimed for equitable vaccine access. ii. The Executive Board (EB): The EB acts as the WHO's executive arm, providing guidance and implementing WHA decisions. It comprises representatives from 34 member states elected for staggered three-year terms. In the early stages of the pandemic, the EB played a critical role by declaring a Public Health Emergency of International Concern (PHEIC) for COVID-19, a vital step in triggering a coordinated international response. iii. The Secretariat: The WHO's permanent administrative body is the Secretariat, headed by the Director-General who leads daily operations. The Director-General is nominated by the EB and elected by the WHA.
During the COVID-19 pandemic, the WHO Secretariat coordinated the global response by issuing technical guidance, deploying experts to affected countries, and facilitating research collaborations. 10 B. Decision-Making Processes- The WHO's decision-making process involves a complex interplay between the WHA, EB, and the Secretariat. The WHA sets the broad policy direction, while the EB provides more specific guidance and oversees implementation. The Secretariat, under the Director-General's leadership, executes these decisions and provides technical expertise. This collaborative approach fosters inclusivity and ensures that the WHO's decisions reflect the needs of its member states. However, it can also be slow and cumbersome, particularly during a fast-moving pandemic where swift action is crucial.
The time taken by the WHO to declare a PHEIC for COVID-19 has been a subject of debate, with some arguing that a quicker response could have potentially mitigated the pandemic's spread. C. Funding Sources- The WHO's funding comes from a variety of sources, including: i. Assessed contributions from member states. ii. Voluntary contributions from UN agencies, philanthropic organizations, and the private sector. This multi-sourced approach helps maintain financial stability but raises concerns about potential donor influence, particularly on issues where powerful member states have vested interests. During the COVID-19 pandemic, the WHO faced criticism for its alleged dependence on funding from China, leading to accusations of bias in its early pronouncements about the virus.
This episode highlights the potential challenges associated with the WHO's funding structure and the need for a more diversified funding base to safeguard its independence. D. The Evolving Landscape- The COVID-19 pandemic has exposed both the strengths and weaknesses of the WHO's structure and governance. The organization's collaborative decision-making process, while ensuring inclusivity, can be slow in times of crisis. Similarly, the WHO's reliance on member state contributions, while fostering financial stability, can raise concerns about undue influence from powerful donors. E. Reforming the WHO: Post-Pandemic Priorities- Discussions are underway in the post-pandemic world to strengthen the WHO's structure and governance. Proposals include streamlining the decision-making process to allow for swifter responses to future health emergencies.
There is also a call for increased and more predictable funding from member states to lessen reliance on voluntary contributions and ensure the WHO's independence. The WHO is also advocating for a new international treaty on pandemic preparedness, prevention, and response. This treaty aims to establish stronger global commitments to financing, surveillance, research, and risk reduction measures to prevent future pandemics and ensure a more coordinated global response. The WHO's structure and governance play a critical role in shaping its effectiveness in addressing global health challenges. The organization's collaborative approach fosters inclusivity but can be slow-moving. The multi-sourced funding approach offers financial stability but raises concerns about potential donor influence.
As the world navigates a post-pandemic landscape, strengthening the WHO's structure and governance will be crucial in ensuring its preparedness for future health threats. 11
6. WHO’s Response to Covid 19 Pandemic
The emergence of the novel coronavirus, SARS-CoV-2, in late 2019 and its subsequent rapid global spread presented an unprecedented challenge for international health organizations. The World Health Organization (WHO) played a central role in coordinating the global response to the COVID-19 pandemic. This paper examines the WHO's actions throughout the crisis, analyzing its strengths and weaknesses in areas like surveillance, guidance, and resource mobilization. i. Early Detection and Outbreak Alert: The WHO's ability to detect and report emerging infectious diseases is critical for prompt global action. In December 2019, China alerted the WHO of a cluster of pneumonia cases of unknown cause in Wuhan. The WHO issued its first situation report on the outbreak on January 4, 2020, highlighting the potential for international spread.
This early detection allowed countries to initiate preparedness measures, even if limitations in initial information about the virus hampered early responses. 12 ii. Guidance and Recommendations: Throughout the pandemic, the WHO issued regular technical guidance documents for governments and healthcare workers. These guidelines covered topics like case definitions, diagnostic testing, clinical management, public health measures, and infection prevention and control. The rapid development and dissemination of this guidance were crucial for establishing a baseline for national response strategies. 13 iii. The Strategic Preparedness and Response Plan (SPRP): In February 2020, the WHO published its first SPRP, outlining a comprehensive global strategy to combat COVID-19. The SPRP focused on five pillars: surveillance, preparedness, risk communication, community engagement, and research.
This plan provided a framework for national and international efforts, highlighting the need for a coordinated approach. 14 iv. The Solidarity Trial and Vaccine Development: Recognizing the urgent need for effective treatments and vaccines, the WHO launched the Solidarity Trial in March 2020. This international clinical trial evaluated the safety and efficacy of various therapeutic interventions for COVID-19. It played a significant role in accelerating research efforts and identifying effective treatment options. 15 v. The COVAX Initiative: Equitable access to vaccines was a major concern during the pandemic. The WHO co-led the COVAX Initiative, a global collaboration aimed at ensuring equitable access to safe and effective COVID-
19 vaccines for all countries. COVAX played a crucial role in securing vaccine
doses for low- and middle-income countries, promoting vaccine equity and reducing the risk of vaccine nationalism. 16 vi. Challenges and Criticisms: Despite its significant contributions, the WHO's response to the pandemic was not without criticism. The initial delay in declaring COVID-19 a Public Health Emergency of International Concern (PHEIC) in January 2020 raised questions about the organization's responsiveness. Additionally, concerns were voiced regarding the early guidance on travel restrictions and the adequacy of support provided to lowand middle-income countries. The WHO's response to the COVID-19 pandemic has been a complex and multifaceted undertaking. The organization played a leading role in coordinating the global response, providing technical guidance, promoting research and development, and facilitating equitable access to vaccines.
However, the pandemic also exposed areas for improvement, such as the need for a more rapid and decisive response during emerging outbreaks and ensuring stronger support for developing countries. As the COVID-19 pandemic transitions into a more manageable phase, the WHO's role remains critical. The organization needs to focus on strengthening its capacity for early detection and outbreak response, fostering international cooperation in public health preparedness, and addressing ongoing challenges related to vaccine hesitancy and misinformation. By learning from the experiences of the COVID-19 pandemic, the WHO can ensure a more effective and equitable response to future global health threats.
7. Need of WHO to fight Covid 19 Pandemic
i. The World Health Organization (WHO) has formulated a Strategic Preparedness and Response Plan for COVID-19, outlining crucial actions for countries to undertake along with the necessary resources to implement them. This plan undergoes regular updates to incorporate new insights and data, refining WHO's understanding of the virus's characteristics and optimal response strategies. It serves as a blueprint for tailoring country-specific preparedness plans. Working closely with governments worldwide, WHO's six regional offices and 150 country offices assist in fortifying health systems against the impacts of COVID-19 and ensuring an effective response as cases emerge and escalate. In collaboration with various partners, WHO has established the COVID-19 Solidarity Response Fund.
This initiative aims to guarantee adequate care for patients, provide frontline workers with essential supplies and information, and expedite the development of vaccines and treatments. To date, the response fund has garnered pledges and contributions exceeding $800 million from governments, the private sector, and individuals. ii. Amidst the vast sea of information circulating on the internet regarding the pandemic, there exists a mixture of valuable insights and misleading content. Recognizing this challenge, the World Health Organization (WHO) is diligently crafting accurate and beneficial guidance aimed at safeguarding lives. This guidance encompasses approximately 50 technical advisories tailored for various audiences, including the general public, healthcare professionals, and governments.
Each piece of advice is meticulously curated, drawing upon evidence-based practices and debunking harmful myths. WHO leverages the expertise of a diverse array of health professionals and scientists worldwide, including epidemiologists, clinicians, and virologists, to ensure the guidance is comprehensive, authoritative, and inclusive. To maintain the integrity and utility of its information, WHO has established a dedicated team tasked with providing timely, accurate, and easily understandable advice from reputable sources. Furthermore, daily situation reports, press briefings, and government engagements serve to keep the global community abreast of the latest developments, data, and evidence. Collaboration with various social media and tech platforms, such as Instagram, LinkedIn, TikTok, WhatsApp, and Viber, has facilitated the dissemination of reliable information.
Chatbots deployed on these platforms have amassed millions of followers, delivering timely updates and reports to enhance public awareness and understanding. iii. Ensuring the availability of personal protective equipment (PPE) is paramount for safeguarding the lives of healthcare workers, as well as their patients. To date, the World Health Organization (WHO) has dispatched over two million units of PPE to 133 countries, with plans underway to send an additional two million units in the upcoming weeks. Additionally, over a million diagnostic tests have been distributed to 126 countries across all regions, with ongoing efforts to secure more. However, the demand for such critical supplies far surpasses the current supply.
In response, WHO is collaborating with entities such as the International Chamber of Commerce and the World Economic Forum, alongside other private sector partners, to bolster the production and distribution of essential medical supplies. To further expedite these efforts, on April 8th, WHO inaugurated the "UN COVID-19 Supply Chain Task Force". This task force aims to significantly enhance the availability of essential protective equipment in areas where it is most urgently required. iv. WHO is actively engaged in training millions of healthcare workers through its Open WHO platform. This online resource plays a crucial role in disseminating life-saving knowledge to frontline personnel, facilitated by the Organization and its key collaborators. Participants engage in a global social learning network, accessing interactive online courses and materials covering a wide range of topics.
Open WHO serves not only as a platform for knowledge transfer but also as a forum for swift exchange of public health expertise and in-depth discussions on critical issues. To date, over 1. 2 million individuals have enrolled in courses offered in 43 languages. In addition to training initiatives, countries receive support from experts deployed worldwide by WHO's Global Outbreak Alert and Response Network (GOARN). This network ensures that the necessary technical expertise and skills are available on-site during outbreaks, precisely where and when they are most needed. Emergency Medical Teams (EMTs) constitute another vital component of the global health workforce. These teams, characterized by their high level of training and self-sufficiency, are deployed to areas designated as disaster or emergency zones. vi.
In numerous countries, laboratories are currently engaged in conducting tests with the hopeful anticipation of developing a vaccine in due course. In an effort to streamline these endeavors, the World Health Organization (WHO) convened
400 esteemed researchers globally in February to delineate research priorities.
As part of its initiatives, the agency initiated the "Solidarity Trial," an international clinical study spanning across 90 countries aimed at identifying effective treatment modalities. The primary objective is to swiftly ascertain whether existing medications can mitigate the progression of the disease or enhance survival rates. In pursuit of a deeper comprehension of the virus, WHO has formulated research protocols adopted by over 40 countries in a synchronized manner. Furthermore, a collaborative statement has been endorsed by approximately 130 scientists, funders, and manufacturers worldwide, pledging their commitment to collaborate with WHO to expedite the development of a COVID-19 vaccine.17
8. Role of WHO in Post Pandemic Recovery
The COVID-19 pandemic has fundamentally reshaped the global landscape, leaving behind a trail of economic and social devastation alongside lingering health concerns. As countries navigate the complex path towards recovery, the World Health Organization (WHO) stands as a critical player in fostering a more resilient and equitable future. This paper will explore the multifaceted role of WHO in postpandemic recovery, highlighting its ongoing efforts and areas for further contribution. i. Strengthening Health Systems: Building Back Better One of the most critical consequences of the pandemic has been the disruption of essential health services. Lockdowns and resource constraints diverted attention away from routine healthcare, leading to a backlog in vaccinations, chronic disease management, and mental health support.
WHO's role in this context is to provide technical assistance and guidance to member states as they rebuild their health systems. This includes: A. Developing and disseminating best practices for strengthening health system infrastructure. This involves prioritizing primary healthcare delivery, investing in digital health solutions, and ensuring the availability of a skilled workforce. 18 B. Supporting the integration of COVID-19 services into routine healthcare. As the pandemic transitions to an endemic stage, WHO can assist countries in seamlessly incorporating COVID-19 vaccinations, testing, and treatment into existing healthcare structures. 19 ii. Addressing Mental Health Fallout: A Silent Crisis The pandemic has triggered a global mental health crisis, with increased rates of anxiety, depression, and post-traumatic stress disorder (PTSD).
WHO plays a crucial role in promoting mental health services and advocating for their inclusion in recovery plans. Key areas of focus include: A. Developing evidence-based guidelines for mental health interventions, specifically targeting vulnerable populations. This encompasses strategies for supporting healthcare workers, frontline responders, and individuals who have lost loved ones. 20 B. Supporting capacity building for mental health professionals. The pandemic exposed workforce shortages in the mental health sector. WHO can assist countries in training additional personnel and integrating mental health services into primary care settings. iii. Ensuring Equitable Access to Vaccines and Treatments The COVID-19 pandemic exposed stark inequities in global vaccine access.
While some nations secured early supplies of vaccines, many low- and middle-income countries (LMICs) struggled to vaccinate their populations. To ensure a more equitable recovery, WHO is central to initiatives like: a. The COVAX Facility: This WHO-led initiative aims to provide equitable access to COVID-19 vaccines for all countries, regardless of their income level. 21 iv. Building Pan-Pandemic Preparedness: Lessons Learned The pandemic exposed vulnerabilities in global health security preparedness. One crucial area for WHO's post-pandemic contribution is collaborating with member states to build robust public health surveillance systems. This includes: a. Strengthening global disease alert systems: Early detection and reporting of infectious diseases will be crucial for preventing future outbreaks from spiralling into pandemics. b.
Investing in research and development (R&D): Supporting R&D for diagnostics, vaccines, and therapeutics will contribute to a faster and more effective response to future health threats. 22 The WHO's role in post-pandemic recovery is multifaceted and critical. By fostering collaboration, providing technical expertise, and advocating for equitable access to health resources, the organization can play a central role in building a more resilient and equitable future. However, the success of these efforts depends not only on WHO's leadership but also on sustained commitment from member states and a recognition of the interconnected nature of global health. Navigating the post-pandemic landscape requires a collective international effort, with WHO at the helm, to ensure a healthier and more secure future for all.
9. Conclusion
In conclusion, the World Health Organization (WHO) has played a pivotal role in global health governance during the COVID-19 pandemic and is poised to continue its significant contributions in the post-pandemic era. Throughout its history, WHO has been at the forefront of international efforts to address public health challenges, guided by its mandate to promote health, prevent diseases, and ensure access to essential health services for all. During the COVID-19 pandemic, WHO swiftly mobilized resources, provided technical guidance, and facilitated global cooperation to combat the spread of the virus. Its leadership in coordinating the global response, disseminating accurate information, and supporting countries with limited healthcare infrastructure has been indispensable in mitigating the impact of the pandemic.
However, WHO faced criticism and challenges, including delays in declaring a Public Health Emergency of International Concern (PHEIC) and concerns regarding transparency and accountability. Looking ahead to the post-pandemic period, WHO's role remains crucial in addressing the long-term health consequences of COVID-19, strengthening health systems, and preparing for future pandemics. As countries strive to recover and rebuild, WHO can provide guidance on health policy, promote equitable access to vaccines and treatments, and support efforts to address underlying determinants of health inequalities. To fulfill its mandate effectively, WHO must address key challenges and opportunities.
This includes securing sustainable funding, enhancing transparency and accountability mechanisms, strengthening partnerships with member states and other stakeholders, and prioritizing equity in global health initiatives. Additionally, WHO should continue to advocate for the integration of health considerations into broader development agendas, recognizing the interconnectedness of health with other sectors such as education, environment, and economy. In conclusion, WHO remains an indispensable actor in global health governance, particularly in the context of pandemics. By upholding its core values of integrity, professionalism, and respect for human rights, WHO can continue to lead efforts to promote health and well-being for all, leaving no one behind.
References • S. K. Kapoor, International Law and Human Rights, 22nd edition • Norman Howard-Jones, The scientific background of the International Sanitary Conferences 1851-1938, available at: https://iris. who. int/bitstream/handle/10665/62873/14549_eng. pdf? sequence=1, last visited on 4/05/2024. • World Health Organization (WHO), International Health Regulations (2005). Official website of World Health Organization, available at https://www. who. int/publications , last visited on 6th April, 2024. • World Health Organization, Constitution of the World Health Organization (1948), available at https://apps. who. int/gb/bd/PDF/bd47/EN/constitution-en. pdf? ua=1 , last visited on 6th April, 2024. • World Health Organisation, Official website of World Health Organisation, https://www. who. int/, accessed May 4, 2024.
• World Health Organization, "Strengthening health information systems," https://www. who. int/activities/integrating-rehabilitation-into-healthsystems/information, accessed May 4, 2024. • World Health Organization, International Health Regulations (IHR), available at https://www. who. int/ihr/publications/9789241596664/en/, last visited on 6th April, 2024. • World Health Organisation, Official website of World Health Organisation, available at https://www. who. int/ , last visited at 6th April, 2024 • World Health Organisation official website, Emergencies Situation Reports, available at https://www. who. int/emergencies/situation-reports, last visited at 6th April, 2024 • World Health Organisation official website, Coronavirus Disease (COVID-19) Technical Guidance, available at https://www. who.
int/emergencies/diseases/novelcoronavirus-2019/technical-guidance, last visited at 6/04/2024.
World Health Organization official website, Strategic Preparedness and Response Plan for the New Coronavirus, available at https://www. who. int/publications-detailredirect/strategic-preparedness-and-response-plan-for-the-new-coronavirus, last visited at 6/04/2024. • World Health Organization official website, Global Research on Novel Coronavirus (2019-nCoV): Solidarity Clinical Trial for COVID-19 Treatments, available at https://www. who. int/emergencies/diseases/novel-coronavirus-2019/global-researchon-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments, last visited at 6/04/2024. • The Washington Post, Gavi and Covax Phase Out Coronavirus Vaccine Donations, available at http://www. washingtonpost. com/world/2022/12/07/gavi-covax-phase-outcoronavirus/, last visited at 6/04/2024.
• United Nations News, 5 reasons the world needs WHO, to fight the COVID-19 pandemic, available at https://news. un. org/en/story/2020/04/1061412 , last visited on 6/04/2024 • World Health Organisation official website, Health System Resilience, available at https://www. who. int/teams/primary-health-care/health-systems-resilience , last visited on 6/04/2024 • World Health Organisation official website, Operational considerations for case management of COVID-19 in health facility and community, available at https://www. who. int/publications-detail-redirect/10665-331492 , last visited on 6/04/2024 • World Health Organisation official website, Mental health and COVID-19, available at https://www. who. int/teams/mental-health-and-substance-use/mental-health-andcovid-19 , last visited on 6/04/2024 • The Vaccine Alliance, Covax Facility, Gavi, available at https://www. gavi.
org/covaxfacility , last visited on 6/04/2024
World Health Organisation official website, Global Research and Innovation for Health Emergencies: Report 2023, available at https://cdn.who.int/media/docs/defaultsource/documents/r-d-blueprint-meetings/global-research-and-innovation-for-healthemergencies_report-2023.pdf?sfvrsn=9341366_2&download=true , last visited on 6th April, 2024